Dev Kamdar, MD
Otolaryngology · Detroit, MINPI 1982801049
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,455 of the $11,028 with a category attached, or 85.7%. Regeneron accounts for 90.2% of it on its own, with 8 other manufacturers making up the rest. Among otolaryngology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $380.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$10K
- Aerin Medical Inc.$271
- Neurent Medical Limited$172
- Dilon Technologies, Inc.$153
- Genentech USA, Inc.$150
- Inspire Medical Systems, Inc.$150
- plus $179 from 3 others
What the payments were for
- Consulting fees$9,45586%
- Food & beverage$1,57314%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 14 | $9,953 |
| Aerin Medical Inc. | 4 | $271 |
| Neurent Medical Limited | 1 | $172 |
| Dilon Technologies, Inc. | 1 | $153 |
| Genentech USA, Inc. | 1 | $150 |
| Inspire Medical Systems, Inc. | 3 | $150 |
| Optinose US, Inc. | 2 | $122 |
| Stryker | 2 | $40 |
| Intuitive Surgical | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIBTAYO$3,487
- NEUROMARK Device$172
- NEUROMARK Radiofrequency Console$172
- HemoBlast Bellows$153
- XOLAIR$150
- VIVAER STYLUS$147
- RHINAER STYLUS$147
- Inspire$121
- Xhance$118
How this compares
$11,028 in reported general payments places this provider in the 90th percentile of 257 otolaryngology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 11 | $1,073 |
| Fluticasone Propionate | 43 | $490 |
| Famotidine | 89 | $248 |
| Oxycodone Hcl | 18 | $245 |
| Levothyroxine Sodium | 29 | $123 |
| Omeprazole | 16 | $99 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $88 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Detroit
- Lamont JonesDetroit$52K
- John CraigDetroit$39K
- Ho Sheng LinDetroit$29K
- Robert DeebDetroit$15K
- Jake SimsDetroit$9K
- Jonathan WaxmanDetroit$7K
- Jacob EideDetroit$4K
- Justin GraffDetroit$4K
- Suhael MominDetroit$4K
- Charles BoydBirmingham$825K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.